9.05
1.74%
-0.16
시간 외 거래:
9.09
0.04
+0.44%
전일 마감가:
$9.21
열려 있는:
$9.39
하루 거래량:
4.36M
Relative Volume:
0.81
시가총액:
$1.58B
수익:
$2.61B
순이익/손실:
$-1.01B
주가수익비율:
-0.367
EPS:
-24.66
순현금흐름:
$195.87M
1주 성능:
-7.75%
1개월 성능:
-8.03%
6개월 성능:
-28.91%
1년 성능:
-47.29%
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
2 MANHATTANVILLE ROAD, PURCHASE, NY
TDOC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
TDOC | 9.05 | 1.58B | 2.61B | -1.01B | 195.87M | -24.66 |
VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
2024-01-03 | 개시 | Barclays | Overweight |
2023-04-12 | 개시 | Stephens | Equal-Weight |
2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | 개시 | Truist | Hold |
2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
2022-08-12 | 개시 | DA Davidson | Buy |
2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
2022-07-06 | 재확인 | BofA Securities | Neutral |
2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2022-04-07 | 개시 | Guggenheim | Buy |
2022-04-01 | 재개 | Credit Suisse | Outperform |
2022-03-03 | 업그레이드 | Argus | Hold → Buy |
2022-02-23 | 재확인 | BofA Securities | Neutral |
2022-02-23 | 재확인 | Craig Hallum | Hold |
2022-02-23 | 재확인 | Evercore ISI | In-line |
2022-02-23 | 재확인 | Goldman | Buy |
2022-02-23 | 재확인 | JP Morgan | Overweight |
2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
2022-02-23 | 재확인 | Needham | Buy |
2022-02-23 | 재확인 | Oppenheimer | Outperform |
2022-02-23 | 재확인 | Stifel | Hold |
2022-02-11 | 개시 | Goldman | Buy |
2022-02-08 | 재확인 | Piper Sandler | Overweight |
2021-12-02 | 재개 | Jefferies | Hold |
2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
2021-10-28 | 재확인 | Barclays | Equal Weight |
2021-10-28 | 재확인 | BofA Securities | Neutral |
2021-10-28 | 재확인 | Canaccord Genuity | Buy |
2021-10-28 | 재확인 | Citigroup | Buy |
2021-10-28 | 재확인 | Craig Hallum | Hold |
2021-10-28 | 재확인 | Needham | Buy |
2021-10-28 | 재확인 | Oppenheimer | Outperform |
2021-10-28 | 재확인 | Piper Sandler | Overweight |
2021-10-28 | 재확인 | UBS | Neutral |
2021-10-19 | 개시 | Wells Fargo | Overweight |
2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2021-05-28 | 개시 | Robert W. Baird | Neutral |
2021-04-15 | 개시 | Needham | Buy |
2021-01-07 | 개시 | BTIG Research | Buy |
2020-12-22 | 개시 | Evercore ISI | In-line |
2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2020-12-04 | 개시 | Goldman | Neutral |
2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2020-09-22 | 개시 | DA Davidson | Buy |
2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2020-07-14 | 개시 | Citigroup | Buy |
2020-07-13 | 개시 | Argus | Buy |
2020-07-07 | 개시 | Stephens | Overweight |
2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
2020-04-13 | 개시 | SVB Leerink | Outperform |
2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-01-10 | 개시 | UBS | Neutral |
2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today - AOL
Telemental Health Market: Growth, Opportunities, and Challenges - openPR
Brokers Offer Predictions for Teladoc Health FY2024 Earnings - MarketBeat
Where Will Teladoc Be in 5 Years? - Yahoo Finance
TDOC (Teladoc Health) Cash From Other Investing Activities : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Goldman Sachs Initiates Coverage of Teladoc Health (TDOC) with Buy Recommendation - MSN
Teladoc Health (NYSE:TDOC) Shares Gap UpShould You Buy? - MarketBeat
Teladoc started at buy at Goldman Sachs on membership, revenue growth - MSN
Teladoc Health (NYSE:TDOC) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Goldman Sachs sets Teladoc target at $14 with Buy rating - Investing.com
Teladoc's SWOT analysis: virtual care leader's stock faces growth hurdles - Investing.com
Is Teladoc Health Stock A Buy? - Barchart
Entropy Technologies LP Reduces Stock Position in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Is Teladoc Health Stock a Buy? - AOL
Virtual Care Market to Achieve a Superb CAGR from 2024 To 2031 - openPR
Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Future-Proofing Growth of Telemedicine Appointment Tools - openPR
Hims & Hers, Talkspace among Q3 winners in digital health - Modern Healthcare
Distance Health Technology Market: Future Scope, Growth - openPR
Telehealth Solutions Market Outlook: Competitor Insights - openPR
(TDOC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Robeco Institutional Asset Management B.V. Boosts Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Telehealth company Boulder Care raises profile with prominent executive hires - Fierce healthcare
Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 - StockTitan
Online Doctor Consultation Market to Grow by USD 38.87 Billion from 2024-2028, Driven by Rising Infectious Diseases and AI-Driven Market TransformationTechnavio - The Malaysian Reserve
ISRG: 3 Healthcare Stocks Innovating with AI - StockNews.com
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit - MSN
Every Teladoc Investor Should Keep an Eye on This Number - Yahoo Finance
Teladoc Health (NYSE:TDOC) Trading Down 7.3%What's Next? - MarketBeat
Teladoc Health Q4 EPS Estimate Lowered by Leerink Partnrs - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Simply Wall St
Teladoc Health (NYSE:TDOC) Price Target Raised to $12.00 - MarketBeat
Leerink Partnrs Comments on Teladoc Health Q1 Earnings - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Q3 2024 Earnings Call Transcript - Insider Monkey
TDOC (Teladoc Health) Cash From Discontinued Investing Acti - GuruFocus.com
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 By Investing.com - Investing.com South Africa
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 - Investing.com Australia
'3Q print less bad than feared', Citi lifts Teladoc stock PT to $11 - Investing.com
Former Teladoc Executive and Healthcare Operations Veteran Jennifer Close Joins Curai Health as Chief Operating Officer - PR Newswire
Teladoc Health (NYSE:TDOC) Sees Unusually-High Trading Volume on Earnings Beat - MarketBeat
December 13th Options Now Available For Teladoc Health (TDOC) - Nasdaq
Teladoc stock rises 7% as Q3 earnings, forecast top Street estimates - MSN
Teladoc stock soars 11% after earnings beat By Investing.com - Investing.com South Africa
Teladoc (TDOC) PT Raised to $11 at Citi - StreetInsider.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navi - GuruFocus.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navigating Challenges and Strategic ... - Yahoo Finance
Teladoc Health Reports Q3 2024 Financial Results - TipRanks
Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Teladoc (NYSE:TDOC) Surprises With Q3 Sales, Stock Jumps 10.3% - Yahoo Finance
Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10% - Benzinga
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):